Innate Pharma

Innate Pharma is a France-based biotechnology company that develops and commercializes therapeutic antibodies for the treatment of cancer and inflammatory diseases.

Business Model:

Revenue: $28M

Employees: 201-500

Detailed Innate Pharma Information

Geographic Data

Innate Pharma headquarters map

Address: 117, Avenue de Luminy

City: Marseille

State: provence-alpes-côte-d'azur

Zip: 13 009

Country: FR

Financial Info

Stage:

post ipo debt

Raised Last:

$32M

Raised Total:

$174M

Metrics

1,644,984Website Global Rank

15,156Website Monthly Traffic

Twitter Followers

Description

Innate Pharma is a France-based biotechnology company that develops and commercializes therapeutic antibodies for the treatment of cancer and inflammatory diseases.

Contact Phone:

Contact Email:

Innate Pharma went public on 10/17/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/17/2019

IPO Valuation:
$420M

Ticker Symbol:
IPHA

IPO Price:
$5.5/share

Amount Raised:
$69M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2022 Post-IPO Debt $32.4M Société Générale
BNP Paribas
10/2018 Corporate Round $0 AstraZeneca
AstraZeneca
1/2022 Post-IPO Debt $0 Societe Generale
BNP Paribas
Societe Generale
BNP Paribas
11/2013 Post-IPO Equity 2 $27.3M QVT Financial
Redmile Group
QVT Financial
Redmile Group
6/2014 Post-IPO Equity $68M
9/2004 Series C $0 Novo Nordisk
Ardian
Ace Capital Partners
NIF SMBC Ventures
Akka Venture
Sofinnova Partners
Gimv
Auriga Partners
Novo Nordisk
Ardian
Ace Capital Partners
NIF SMBC Ventures
Akka Venture
Sofinnova Partners
Gimv
Auriga Partners
1/2002 Series B 6 $17.8M Sofinnova Partners
Gimv
Gilde Healthcare
Auriga Partners
Ardian
Akka Venture
11/2006 IPO $38.3M
11/2013 Private Placement $27.4M
8/2020 Grant $2M Bpifrance
10/2018 Corporate Round $71.9M AstraZeneca
3/2000 Series A 3 $4.4M Sofinnova Partners
Gimv
Auriga Partners
Sofinnova Partners
1/2022 Post-IPO Debt 2 $32.5M BNP Paribas
Societe Generale
BNP Paribas
Societe Generale
10/2018 Corporate Round 1 $71.4M AstraZeneca
AstraZeneca
AstraZeneca
AstraZeneca
9/2004 Series C 8 $18.3M Ardian
Ace Capital Partners
NIF SMBC Ventures
Novo Nordisk
Akka Venture
Ardian
Ace Capital Partners
NIF SMBC Ventures
Novo Nordisk
Akka Venture
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research